# OnCo record constellation-pharmaceuticals (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/constellation-pharmaceuticals/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "constellation-pharmaceuticals" ;
  schema:name "Constellation Pharmaceuticals"@en ;
  schema:alternateName "Constellation Pharmaceuticals, Inc."@en ;
  schema:description "Constellation Pharmaceuticals developed medicines for cancer that change which genes are switched on in cancer cells. MorphoSys bought it in 2021, and its drugs pelabresib and CPI-0209 (now tulmimetostat) went with it."@en ;
  schema:url <https://onco.cc/companies/constellation-pharmaceuticals/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://www.sec.gov/Archives/edgar/data/1340243/000119312521215759/d193747dex991.htm>, <https://www.thirdrockventures.com/portfolio/constellation> ;
  schema:addressCountry "US" ;
  onco:sections <https://onco.cc/fronts/epigenetics/> ;
  onco:drugs <https://onco.cc/drugs/pelabresib/>, <https://onco.cc/drugs/tulmimetostat/> .